From: Statistical considerations for stopping systemic lupus erythematosus clinical trials earlier
Scalea | Minimum and maximum | Description |
---|---|---|
SLAM | 0 to 84 | Systemic Lupus Activity Measure |
SLEDAI | 0 to 108 | Systemic Lupus Erythematosus Disease Activity Index |
BILAG | 0 to 180 | British Isles Lupus Assessment Group |
ECLAM | 0 to 15.5 | European Consensus Lupus Activity Measure |